Morphological Signs of Intravital Contraction (Retraction) of Pulmonary Thrombotic Emboli
- 48 Downloads
The goal of the study was to establish whether contraction (retraction) of thrombi and/or thrombotic emboli occurs in vivo using morphological signs of blood clot compression, such as characteristic deformation of erythrocytes and redistribution of fibrin toward the surface of a thrombus/embolus. Three postmortem human pulmonary thrombotic emboli were examined by scanning electron microscopy and light microscopy after staining with hematoxylin and eosin as well as with Mallory’s stain. In two pulmonary emboli, which were extracted at 7 and 15 h after death of the patients, compressed polyhedral erythrocytes (polyhedrocytes) were revealed that were formed due to mechanical deformation under the action of contractile forces generated by activated platelets. In addition, the uneven distribution of fibrin within the emboli was found with accumulation of fibrin at the periphery of the emboli, which is another structural characteristic of a contracted blood clot. In one of the three emboli analyzed, which was extracted 38 h after the patient’s death (the “oldest” embolus), the morphological signs of contraction were absent, which was likely related to the partial postmortem autolysis of the embolus or intravital impairment of contraction. The ex vivo thrombotic emboli have morphological signs of clot contraction, suggesting intravital compression of the primary thrombi and/or thrombotic emboli. The in vivo contraction of thrombi and emboli may be an important pathogenic mechanism for modulation of blood flow past otherwise obstructive clots at the sites of thrombotic occlusion of a vessel. The presence of compressed erythrocytes inside and the predominant location of fibrin around the periphery of a thrombus or embolus can potentially serve as additional pathomorphological criteria for the intravital contraction of thrombi and thrombotic emboli.
KeywordsThrombosis Thromboembolism Clot contraction Clot retraction
The work was supported by NIH grants HL-090774 and UO1HL116330, National Science Foundation grant DMR1505662, and the Program for Competitive Growth at Kazan Federal University.
Compliance with Ethical Standards
Conflict of Interest
The authors declare that they have no conflict of interest.
- 1.Wells, P., & Anderson, D. (2013). The diagnosis and treatment of venous thromboembolism. Hematology. American Society of Hematology. Education Program, 2013, 457–463.Google Scholar
- 4.Bĕlohlávek, J., Dytrych, V., & Linhart, A. (2013). Pulmonary embolism, part I: epidemiology, risk factors and risk stratification, pathophysiology, clinical presentation, diagnosis and nonthrombotic pulmonary embolism. Experimental and Clinical Cardiology, 18(2), 129–138.Google Scholar
- 10.Peshkova, A. D., Le Minh, G., Tutwiler, V., Andrianova, I. A., Weisel, J. W., & Litvinov, R. I. (2017). Activated monocytes enhance platelet-driven contraction of blood clots via tissue factor expression. Scientific Reports, 7(1), 5149. https://doi.org/10.1038/s41598-017-05601-9.CrossRefGoogle Scholar
- 13.Xu, S., Xu, Z., Kim, O., Litvinov, R. I., Weisel, J. W., & Alber, M. (2017). Model predictions of deformation, embolization and permeability of partially obstructive blood clots under variable shear flow. Journal of the Royal Society Interface, 14, 20170441.Google Scholar
- 15.Leong, L., Chernysh, I. N., Xu Y., Sim D., Nagaswami C., & de Lange Z. (2017). Clot stability as a determinant of effective factor VIII replacement in hemophilia A. Research and Practice in Thrombosis and Haemostasis, 1, 231–241.Google Scholar